Balaxi Pharmaceuticals Shareholding Pattern
- Market cap
- ₹126 crore
- P/E
- 52.0
- P/B
- 0.51
- ROE
- 0.6%
- Dividend yield
- 1.20%
As of 30-JUN-2026, promoters held 65.99% of Balaxi Pharmaceuticals (0.00 pp from 31-MAR-2026), foreign institutional investors 0.00%, domestic institutions 2.56% and the public 31.45%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Balaxi Pharmaceuticals shareholding pattern — frequently asked questions
What is the promoter holding in Balaxi Pharmaceuticals?
Promoters held 65.99% of Balaxi Pharmaceuticals as of 30-JUN-2026, unchanged from 65.99% in 31-MAR-2026.
How much do FIIs hold in Balaxi Pharmaceuticals?
Foreign institutional investors held 0.00% of Balaxi Pharmaceuticals as of 30-JUN-2026, a change of 0.00 pp from the previous quarter.
How much do domestic institutions hold in Balaxi Pharmaceuticals?
Domestic institutional investors, including mutual funds and insurers, held 2.56% of Balaxi Pharmaceuticals as of 30-JUN-2026 (0.00 pp from the previous quarter).
Who owns Balaxi Pharmaceuticals?
As of 30-JUN-2026, Balaxi Pharmaceuticals' shareholders were promoters (65.99%), foreign institutional investors 0.00%, domestic institutions 2.56% and the public 31.45%, as filed with the stock exchanges.
Same Data For Peers
Trade Balaxi Pharmaceuticals With ATS
Track BALAXI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.